Page 31 - Read Online
P. 31

Lozano-Rosas et al. Hepatoma Res 2018;4:19  I  http://dx.doi.org/10.20517/2394-5079.2018.48                              Page 7 of 14

               encoded by  the  Tmem70  gene,  is  a  protein  of  the  mitochondrial inner membrane  that  participates in
               mitochondrial biogenesis and whose mutations can be associated with the deficiency in the synthesis of
               ATP [70,71] . MRPS12 is a mitoribosomal conserved protein  and MGRAP is an important protein for the
                                                                [72]
               maintenance of mitochondrial morphology and quantity, as well as for the process of steroidogenesis .
                                                                                                    [73]
               Enzymes that catalyze acetylation, methylation, or their loss also regulate epigenetic changes [74,75] . For
               example, the enzyme LSD1 (lysine-specific demethylase 1) uses the mitochondrial cofactor FAD to carry out
               the demethylation of modified histones such as H3K4me1 and H3K4me2 .
                                                                             [76]

               LSD1 has been proposed as a regulator of cell proliferation in several cancer types, as well as its metabolic
               reprogramming [77,78] . In HCC, it has been determined that LSD1 regulates energy production and suppresses
               mitochondrial respiration . These studies also determined that the demethylase activity by LSD1 represses
                                     [78]
               mitochondrial metabolism genes and induces the expression of glycolytic genes .
                                                                                  [78]
               In HCC, differential expression of different miRNAs has been observed, as well as epigenetic modifications .
                                                                                                        [79]

               miR-122 regulation of PGC-1α (peroxisome proliferator activated receptor gamma, coactivator 1 alpha) and
               SDH (succinate dehydrogenase) subunits A and B is necessary for mitochondrial metabolism. In HCC, this
               miRNA is scarcely expressed. Studies propose this microRNA as a tumor suppressor, since in primary HCC
               tumors, in both human and rodents, it is seen at low levels, compared to its healthy controls. Also, in HBV-
               infected patients, this miRNA is reduced in hepatic tissue [45,80,81] . miR-122 is implicated in the control of lipid
               metabolism and circadian regulation in the liver. This microRNA has been observed in steatohepatitis and
               liver fibrosis, in addition to HCC [80,82] . Experimentally, the genetic deletion of miR-122 in mice has important
               effects on lipid metabolism, as well as on the progression of liver disease, from microsteatosis to HCC [80,82] .


               miR-33a/b regulates lipid metabolism through the ABCA1 cholesterol transporter. Its overexpression inhibits
               the oxidation of fatty acids in the liver cancer cell line HuH7, favoring the accumulation of triglycerides in
               larger lipid droplets. MiR-33 binding sites have been identified in the 3 'UTR of genes for mitochondrial
               proteins such as carnitine O-octaniltransferase (CROT) and carnitine palmitoyltransferase 1A (CPT1a).
               This miRNA inhibits also the insulin receptor substrate 2 (ISR2) and regulates insulin signaling [83,84] . There
               is very little information about the role of this miRNA in HCC, so we suggest that this could be studied more
               extensively to determine its importance in this pathology.

               On the other hand, the role of mitochondrial genetic alterations has been investigated in HCC, and tumors
               contained significantly reduced mtDNA and TFAM overexpression, although neither condition correlated
               with the degree of cell differentiation; TFAM expression correlated with tumor size .
                                                                                      [85]
               For all the above, the field of mitoepigenetics has attracted research with the aim of having more effective
               therapeutic targets in the treatment of HCC.

               Mitoepigenetics in tumor-initiating stem-like cells in HCC
               The liver cancer, as other epithelial cancers, has tumor-initiating stem-like cells (TICs) that are implicated
               in tumorigenesis and drug resistance . TICs share some characteristics with embryonic stem cells (ESC)
                                               [86]
               including  expression  of  the  pluripotency  transcription  factors,  NANOG,  OCT4,  MYC,  and  SOX2.  The
               expression of pluripotency transcription factors contributes to cancer progression by reprogramming
               mitochondrial metabolism [87,88] .


               NANOG represses OXPHOS genes, prevents mitochondrial ROS production, and activates fatty acid oxidation
               (FAO), contributing to TIC self-renewal and drug resistance . Low levels of ROS are necessary to preserve
                                                                  [87]
   26   27   28   29   30   31   32   33   34   35   36